Advancements and future directions in research of the roles of insulin in amyloid diseases
Author:
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Biophysical Chemistry
- Vol. 281, 106720
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation (532/15)
This publication has 64 references indexed in Scilit:
- Risk of Parkinson Disease Onset in Patients With DiabetesDiabetes Care, 2012
- Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR)Proceedings of the National Academy of Sciences, 2011
- High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neuronsNature Neuroscience, 2011
- Diabetes and the Risk of Developing Parkinson’s Disease in DenmarkDiabetes Care, 2011
- Insulin metabolism and the risk of Alzheimer diseaseNeurology, 2010
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's DiseaseDiabetes Care, 2008
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005
- 3D structure of Alzheimer's amyloid-β(1–42) fibrilsProceedings of the National Academy of Sciences, 2005
- Zinc–Ligand Interactions Modulate Assembly and Stability of the Insulin Hexamer – A ReviewBioMetals, 2005
- The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylationBiochemical and Biophysical Research Communications, 2004